cabergoline has been researched along with Thymus Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borson-Chazot, F; Ilie, MD; Raverot, G; Raverot, V; Tronc, F; Vasiljevic, A | 1 |
Bodei, L; Colao, A; de Herder, WW; de Krijger, RR; Faggiano, A; Ferone, D; Hofland, LJ; Lamberts, SW; Lombardi, G; Pivonello, R | 1 |
2 other study(ies) available for cabergoline and Thymus Neoplasms
Article | Year |
---|---|
Cabergoline in severe ectopic or occult Cushing's syndrome.
Topics: ACTH Syndrome, Ectopic; Adult; Aged; Cabergoline; Carcinoid Tumor; Cushing Syndrome; Dopamine Agonists; Female; Humans; Hydrocortisone; Ketoconazole; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Intraductal Neoplasms; Rectal Neoplasms; Steroid Synthesis Inhibitors; Thymus Neoplasms; Treatment Outcome | 2019 |
Dopamine receptor expression and function in corticotroph ectopic tumors.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Cabergoline; Ergolines; Female; Humans; Hydrocortisone; Lung Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Receptors, Dopamine; Reverse Transcriptase Polymerase Chain Reaction; Thymus Neoplasms | 2007 |